Drug: bevacizumab Quarter: 2016Q3
Total Drug/Injury Combinations: 786 Number of Pages: 40
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| BEVACIZUMAB 25MG/ML GENENTECH | Haematemesis | 1 | view events |
| BEVACIZUMAB 25MG/ML GENENTECH | Haemoglobin decreased | 1 | view events |
| BEVACIZUMAB 25MG/ML GENENTECH | Nausea | 1 | view events |
| BEVACIZUMAB 25MG/ML GENENTECH | Small intestinal haemorrhage | 1 | view events |
| BEVACIZUMAB 25MG/ML GENENTECH | Vomiting | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Abdominal discomfort | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Abdominal pain | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Chills | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Condition aggravated | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Diarrhoea | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Discomfort | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Hypophagia | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Nausea | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Pyrexia | 1 | view events |
| BEVACIZUMAB 25MG/ML, 4ML VIAL | Vomiting | 1 | view events |
| BEVACIZUMAB 5MG/KG - CONTROL GROUP | Ischaemic stroke | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Alopecia | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Bone marrow failure | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Disease progression | 1 | view events |
| BEVACIZUMAB MONOCLONAL ANTIBODY (MAB) | Epistaxis | 1 | view events |
Total Drug/Injury Combinations: 786 Number of Pages: 40
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)